Impact Factor 2020: 1.226 (@Clarivate Analytics)
5-Year Impact Factor: 2.285 (@Clarivate Analytics)
Immediacy Index: 2.645
  • Users Online: 321
  • Print this page
  • Email this page

    Article Cited by others

REVIEW ARTICLE

The 2019 novel coronavirus disease (COVID-19) pandemic: A zoonotic prospective

Chakraborty Chiranjib, Sharma Ashish Ranjan, Bhattacharya Manojit, Sharma Garima, Lee Sang-Soo

Year : 2020| Volume: 13| Issue : 6 | Page no: 242-246

   This article has been cited by
 
1 SARS-CoV-2: the prospects of the virus spreading and the course of the pathogenesis of coronavirus infection in various species of animals
M. S. Fedotova, A. Yu. Filippova, M. A. Omarov, K. S. Yurchenko, M. A. Gulyaeva
South of Russia: ecology, development. 2022; 17(1): 6
[Pubmed]  [Google Scholar] [DOI]
2 Determinants of COVID-19 Vaccine Acceptance in West Papua, Indonesia
Butet Agustarika, Simon L. Momot, Alva Cherry Mustamu
Open Access Macedonian Journal of Medical Sciences. 2022; 10(E): 274
[Pubmed]  [Google Scholar] [DOI]
3 Reasons for hesitancy to take COVID-19 vaccine: A survey amongst healthcare workers
GSwetha Rao, R Ram, B Vengamma
Journal of Clinical and Scientific Research. 2022; 11(1): 17
[Pubmed]  [Google Scholar] [DOI]
4 EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes
Cristina S. Ferreira, Yasmmin C. Martins, Rangel Celso Souza, Ana Tereza R. Vasconcelos
PeerJ. 2021; 9: e12548
[Pubmed]  [Google Scholar] [DOI]
5 Acceptability of the COVID-19 Vaccine among Adults in Saudi Arabia: A Cross-Sectional Study of the General Population in the Southern Region of Saudi Arabia
Yahya S. Alqahtani
Vaccines. 2021; 10(1): 41
[Pubmed]  [Google Scholar] [DOI]
6 Repurposing of the Herbals as Immune-Boosters in the Prevention and Management of COVID-19: A Review
Rinki Kumari,Anita Venaik,Md Al Hasibuzzaman,Simon Agongo Azure,Rudra P. Ojha,Ajay Kumar Sahi
Journal of Pure and Applied Microbiology. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
7 Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19
Xianfang Tang,Lijun Cai,Yajie Meng,JunLin Xu,Changcheng Lu,Jialiang Yang
Frontiers in Immunology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
8 Ensemble Machine Learning Model to Predict SARS-CoV-2 T-Cell Epitopes as Potential Vaccine Targets
Syed Nisar Hussain Bukhari, Amit Jain, Ehtishamul Haq, Abolfazl Mehbodniya, Julian Webber
Diagnostics. 2021; 11(11): 1990
[Pubmed]  [Google Scholar] [DOI]
9 Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
Kavya Srinivasan, Ashutosh Kumar Pandey, Ashlena Livingston, Sundararajan Venkatesh
Molecular Biomedicine. 2021; 2(1)
[Pubmed]  [Google Scholar] [DOI]
10 Human menstrual blood-derived stem cells as immunoregulatory therapy in COVID-19: A case report and review of the literature
Juan Lu,Zhong-Yang Xie,Dan-Hua Zhu,Lan-Juan Li
World Journal of Clinical Cases. 2021; 9(7): 1705
[Pubmed]  [Google Scholar] [DOI]
11 Reported quality of life in countries with cases of COVID19: a systematic review
Maria Eduarda Melo-Oliveira,Danúbia Sá-Caputo,José Alexandre Bachur,Laisa Liane Paineiras-Domingos,Anelise Sonza,Ana Cristina Lacerda,Vanessa Mendonça,Adérito Seixas,Redha Taiar,Mario Bernardo-Filho
Expert Review of Respiratory Medicine. 2021; 15(2): 213
[Pubmed]  [Google Scholar] [DOI]
12 SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development
Chiranjib Chakraborty,Manojit Bhattacharya,Bidyut Mallick,Ashish Ranjan Sharma,Sang-Soo Lee,Govindasamy Agoramoorthy
Expert Review of Clinical Pharmacology. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
13 Covid-19 vaccine, acceptance, and concern of safety from public perspective in the state of Odisha, India
Dibya Sundar Panda,Ranjan Kumar Giri,Anil Kumar Nagarajappa,Sakeenabi Basha
Human Vaccines & Immunotherapeutics. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
14 Clinical effectiveness of drugs in hospitalized patients with COVID-19: a systematic review and meta-analysis
Roberto Ariel Abeldaño Zuñiga, Silvia Mercedes Coca, Giuliana Florencia Abeldaño, Ruth Ana María González-Villoria
Therapeutic Advances in Respiratory Disease. 2021; 15: 1753466621
[Pubmed]  [Google Scholar] [DOI]
15 A survey on COVID-19 vaccine acceptance and concern among Malaysians
S. A. R. Syed Alwi,E. Rafidah,A. Zurraini,O. Juslina,I. B. Brohi,S. Lukas
BMC Public Health. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
16 Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis
Masoumeh Adhami,Balal Sadeghi,Ali Rezapour,Ali Akbar Haghdoost,Habib MotieGhader
BMC Biotechnology. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
17 Interpretative immune targets and contemporary position for vaccine development against SARS-CoV-2: A systematic review
Nidhi Chauhan,Shringika Soni,Abhinandan Gupta,Mohammad Aslam,Utkarsh Jain
Journal of Medical Virology. 2021; 93(4): 1967
[Pubmed]  [Google Scholar] [DOI]
18 A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics
Jyoti Verma,Naidu Subbarao
Archives of Virology. 2021;
[Pubmed]  [Google Scholar] [DOI]
19 Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19
Seyed Mehdi Sadat,Mohammad Reza Aghadadeghi,Masoume Yousefi,Arezoo Khodaei,Mona Sadat Larijani,Golnaz Bahramali
Molecular Biotechnology. 2021;
[Pubmed]  [Google Scholar] [DOI]
20 Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude
Lei-Yun Wang,Jia-Jia Cui,Qian-Ying OuYang,Yan Zhan,Yi-Min Wang,Xiang-Yang Xu,Lu-Lu Yu,Hui Yin,Yang Wang,Chen-Hui Luo,Cheng-Xian Guo,Ji-Ye Yin
EPMA Journal. 2021;
[Pubmed]  [Google Scholar] [DOI]
21 Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches
Ratnadeep Saha,Pratik Ghosh,V. L. S. Prasad Burra
3 Biotech. 2021; 11(2)
[Pubmed]  [Google Scholar] [DOI]
22 Response to: Status of Remdesivir: Not Yet Beyond Question!
Abinit Saha,Ashish Ranjan Sharma,Manojit Bhattacharya,Garima Sharma,Sang-Soo Lee,Chiranjib Chakraborty
Archives of Medical Research. 2021; 52(1): 104
[Pubmed]  [Google Scholar] [DOI]
23 Are vanadium complexes druggable against the main protease Mpro of SARS-CoV-2? – A computational approach
Thomas Scior,Hassan H. Abdallah,Siti Fatimah Zaharah Mustafa,José Antonio Guevara-García,Dieter Rehder
Inorganica Chimica Acta. 2021; 519: 120287
[Pubmed]  [Google Scholar] [DOI]
24 Efficacy and Safety of Pegylated Interferon alfa-2b in Moderate COVID-19: A phase II, randomized, controlled, open-label study
Anuja Pandit,Nirav Bhalani,B.L. Shashi Bhushan,Parshottam Koradia,Shweta Gargiya,Vinay Bhomia,Kevinkumar Kansagra
International Journal of Infectious Diseases. 2021;
[Pubmed]  [Google Scholar] [DOI]
25 SARS-CoV-2 and other human coronavirus: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics
Chiranjib Chakraborty,Ashish Ranjan Sharma,Manojit Bhattacharya,Rudra P. Saha,Sanmitra Ghosh,Soham Biswas,Saikat Samanta,Garima Sharma,Govindasamy Agoramoorthy,Sang-Soo Lee
Infection, Genetics and Evolution. 2021; : 104729
[Pubmed]  [Google Scholar] [DOI]
26 Challenges faced in establishing a dedicated 250 bed COVID-19 intensive care unit in a temporary structure
Shalendra Singh,George Cherian Ambooken,Rangraj Setlur,Shamik Kr Paul,Madhuri Kanitkar,Surinder Singh Bhatia,Ratnesh Singh Kanwar
Trends in Anaesthesia and Critical Care. 2021; 36: 9
[Pubmed]  [Google Scholar] [DOI]
27 Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines
José Adão Carvalho Nascimento Júnior,Anamaria Mendonça Santos,Rafael Ciro Marques Cavalcante,Lucindo José Quintans-Júnior,Cristiani Isabel Banderó Walker,Lysandro Pinto Borges,Luiza Abrahão Frank,Mairim Russo Serafini
Drug Development and Industrial Pharmacy. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
28 How a catastrophic situation turns into an exceptional opportunity: Covid-19 pandemic in Iran and challenges of online education for new English language educators
Parisa Badrkhani
Interactive Learning Environments. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
29 Diagnosis For COVID-19: Current Status and Future Prospects
Alamgir Kabir,Rajib Ahmed,Sheikh Muhammad Asher Iqbal,Rasheduzzaman Chowdhury,Ramasamy Paulmurugan,Utkan Demirci,Waseem Asghar
Expert Review of Molecular Diagnostics. 2021;
[Pubmed]  [Google Scholar] [DOI]
30 Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection
Soumya Ranjan Mahapatra,Susrita Sahoo,Budheswar Dehury,Vishakha Raina,Shubhransu Patro,Namrata Misra,Mrutyunjay Suar
Expert Review of Vaccines. 2020; 19(9): 871
[Pubmed]  [Google Scholar] [DOI]
31 Ten challenging questions about SARS-CoV-2 and COVID-19
Majid Teymoori-Rad,Saeed Samadizadeh,Alijan Tabarraei,Abdolvahab Moradi,Mahsa Bataghva Shahbaz,Alireza Tahamtan
Expert Review of Respiratory Medicine. 2020; 14(9): 881
[Pubmed]  [Google Scholar] [DOI]
32 Covid-19: a comprehensive review of a formidable foe and the road ahead
Arafat Hussain,Suniti Yadav,Vijay Hadda,Tejas M Suri,Pawan Tiwari,Saurabh Mittal,Karan Madan,Anant Mohan
Expert Review of Respiratory Medicine. 2020; 14(9): 869
[Pubmed]  [Google Scholar] [DOI]
33 Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics framework
Neeraj Kumar,Damini Sood,Ramesh Chandra
RSC Advances. 2020; 10(59): 35856
[Pubmed]  [Google Scholar] [DOI]
34 Simulink Modelling For Simulating Intensive Care Mechanical Ventilators
Paolo Tamburrano,Pietro De Palma,Andrew R. Plummer,Elia Distaso,Riccardo Amirante
E3S Web of Conferences. 2020; 197: 07007
[Pubmed]  [Google Scholar] [DOI]
35 Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex
Manojit Bhattacharya,Ashish Ranjan Sharma,Bidyut Mallick,Garima Sharma,Sang-Soo Lee,Chiranjib Chakraborty
Infection, Genetics and Evolution. 2020; 85: 104587
[Pubmed]  [Google Scholar] [DOI]
36 Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach
Samira Sanami,Milad Zandi,Behzad Pourhossein,Gholam-Reza Mobini,Mohsen Safaei,Atena Abed,Pooria Mohammadi Arvejeh,Fatemeh Amini Chermahini,Morteza Alizadeh
International Journal of Biological Macromolecules. 2020; 164: 871
[Pubmed]  [Google Scholar] [DOI]
37 TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19
Mohammad Azam Ansari,Qazi Mohammad Sajid Jamal,Suriya Rehman,Ahmad Almatroudi,Mohammad A. Alzohairy,Mohammad N. Alomary,Takshashila Tripathi,Ali H. Alharbi,Syed Farooq Adil,Mujeeb Khan,M. Shaheer Malik
Arabian Journal of Chemistry. 2020; 13(11): 8069
[Pubmed]  [Google Scholar] [DOI]
38 Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2
Hong-Zhi Chen,Ling-Li Tang,Xin-Ling Yu,Jie Zhou,Yun-Feng Chang,Xiang Wu
Infectious Diseases of Poverty. 2020; 9(1)
[Pubmed]  [Google Scholar] [DOI]
39

Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey

Mohammed Al-Mohaithef,Bijaya Kumar Padhi
Journal of Multidisciplinary Healthcare. 2020; Volume 13: 1657
[Pubmed]  [Google Scholar] [DOI]
40 Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
José María Díez,Carolina Romero,Júlia Vergara-Alert,Melissa Belló-Perez,Jordi Rodon,José Manuel Honrubia,Joaquim Segalés,Isabel Sola,Luis Enjuanes,Rodrigo Gajardo
Immunotherapy. 2020; 12(17): 1247
[Pubmed]  [Google Scholar] [DOI]
41 Understanding COVID-19: From Origin to Potential Therapeutics
Muhammad Moazzam,Muhammad Imran Sajid,Hamza Shahid,Jahanzaib Butt,Irfan Bashir,Muhammad Jamshaid,Amir Nasrolahi Shirazi,Rakesh Kumar Tiwari
International Journal of Environmental Research and Public Health. 2020; 17(16): 5904
[Pubmed]  [Google Scholar] [DOI]
42 Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
Federica Mannino,Alessandra Bitto,Natasha Irrera
Frontiers in Pharmacology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
43 In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs
Abhigyan Choudhury,Suprabhat Mukherjee
Journal of Medical Virology. 2020; 92(10): 2105
[Pubmed]  [Google Scholar] [DOI]

 

Read this article